KTTAClinical Trials•globenewswire•August 28, 2025 at 11:02 AM

Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sentiment:Negative (30)

Pasithea Tx (Nasdaq: KTTA) to present PAS-004 clinical progress at H.C. Wainwright Global Investment Conference on Sept. 10, 2025 in NYC.

Read the full article from the original source for complete details and context.

Article published on August 28, 2025 by globenewswire